Revelation Biosciences Inc.
13F holders, Q1 2025 (March 31)7holders +6
6new positions
0sold out
$2.73avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Revelation Biosciences Inc. in their 13F filings, up 6 from Q4 2024. 6 opened new positions and 0 sold out. The largest holders were Tower Research Capital LLC (TRC) ($5K), Royal Bank of Canada ($4K) and SBI Securities Co., Ltd. ($1K).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $11K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 4,238 shares bought, net +4,238 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,043 | $5K |
| Royal Bank of Canada | 0.00% | New | 1,353 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Add +74.4% | 525 | $1K |
| UBS Group AG | 0.00% | New | 349 | $918 |
| IFP Advisors, Inc | 0.00% | New | 250 | $658 |
| Bank of America Corp. | 0.00% | New | 18 | $48 |
| Danske Bank A/S | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is REVELATION BIOSCIENCES INC's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.